Global Polymer Drug Conjugates Market Data Survey Report 2013-2025

Publisher Name :
Date: 09-Mar-2019
No. of pages: 72

Summary

The global Polymer Drug Conjugates market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers profile, products & services, sales data of business

Global market size by Major Application

Global market size by Major Type

Key manufacturers are included based on company profile, sales data and product specifications etc.:

- 3S Bio

- Abeona Therapeutics

- Abramson Cancer Center

- Access Pharmaceuticals

- Adama

- Eyetech

- Ferring

- Flamel Technologies

- Genentech

- GlaxoSmithKline

- Gowan

- Gynecologic Oncology Group Foundation

- JenKem Technology

- Landec

- Lipotek

Major applications as follows:

- Cancer Treatment

- Leukmia

- Hepatitis

- Others

Major Type as follows:

- Polymer-Dox Conjugates

- Polymer-Paclitaxel Conjugates

- Polymer-Camptothecin Conjugates

- Polymer-Platinate Conjugates

Regional market size, production data and export & import:

- Asia-Pacific

- North America

- Europe

- South America

- Middle East & Africa

Global Polymer Drug Conjugates Market Data Survey Report 2013-2025

Table of Contents

1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 3S Bio
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Abeona Therapeutics
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Abramson Cancer Center
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Access Pharmaceuticals
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Adama
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Eyetech
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Ferring
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Flamel Technologies
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 Genentech
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 GlaxoSmithKline
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 Gowan
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11.4 Recent Development
3.12 Gynecologic Oncology Group Foundation
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12.4 Recent Development
3.13 JenKem Technology
3.13.1 Company Information
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.13.4 Recent Development
3.14 Landec
3.14.1 Company Information
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.15 Lipotek
3.15.1 Company Information
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Cancer Treatment
4.1.1 Overview
4.1.2 Cancer Treatment Market Size and Forecast
4.2 Leukmia
4.2.1 Overview
4.2.2 Leukmia Market Size and Forecast
4.3 Hepatitis
4.3.1 Overview
4.3.2 Hepatitis Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 Market by Type
5.By Polymer-Dox Conjugates
5.1 Polymer-Dox Conjugates
5.1.1 Overview
5.1.2 Polymer-Dox Conjugates Market Size and Forecast
5.2 Polymer-Paclitaxel Conjugates
5.2.1 Overview
5.2.2 Polymer-Paclitaxel Conjugates Market Size and Forecast
5.3 Polymer-Camptothecin Conjugates
5.3.1 Overview
5.3.2 Polymer-Camptothecin Conjugates Market Size and Forecast
5.4 Polymer-Platinate Conjugates
5.4.1 Overview
5.4.2 Polymer-Platinate Conjugates Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion

List of Tables

Tab Regional Production 2013-2018 (Million USD)
Tab Regional Production 2013-2018 (Volume)
Tab Regional Demand and CAGR 2013-2018 (Million USD)
Tab Regional Demand and CAGR 2013-2018 (Volume)
Tab Regional Demand Forecast and CAGR 2019-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2019-2025 (Volume)
Tab Regional Export 2013-2018 (Million USD)
Tab Regional Export 2013-2018 (Volume)
Tab Regional Import 2013-2018 (Million USD)
Tab Regional Import 2013-2018 (Volume)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of 3S Bio
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Abeona Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Abramson Cancer Center
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Access Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Adama
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eyetech
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Ferring
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Flamel Technologies
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Genentech
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Gowan
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Gynecologic Oncology Group Foundation
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of JenKem Technology
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Landec
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Lipotek

List of Figures

Fig Global Polymer Drug Conjugates Market Size and CAGR 2013-2018 (Million USD)
Fig Global Polymer Drug Conjugates Market Size and CAGR 2013-2018 (Volume)
Fig Global Polymer Drug Conjugates Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Polymer Drug Conjugates Market Forecast and CAGR 2019-2025 (Volume)
Fig Cancer Treatment Market Size and CAGR 2013-2018 (Million USD)
Fig Cancer Treatment Market Size and CAGR 2013-2018 (Volume)
Fig Cancer Treatment Market Forecast and CAGR 2019-2025 (Million USD)
Fig Cancer Treatment Market Forecast and CAGR 2019-2025 (Volume)
Fig Leukmia Market Size and CAGR 2013-2018 (Million USD)
Fig Leukmia Market Size and CAGR 2013-2018 (Volume)
Fig Leukmia Market Forecast and CAGR 2019-2025 (Million USD)
Fig Leukmia Market Forecast and CAGR 2019-2025 (Volume)
Fig Hepatitis Market Size and CAGR 2013-2018 (Million USD)
Fig Hepatitis Market Size and CAGR 2013-2018 (Volume)
Fig Hepatitis Market Forecast and CAGR 2019-2025 (Million USD)
Fig Hepatitis Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)
Fig Polymer-Dox Conjugates Market Size and CAGR 2013-2018 (Million USD)
Fig Polymer-Dox Conjugates Market Size and CAGR 2013-2018 (Volume)
Fig Polymer-Dox Conjugates Market Forecast and CAGR 2019-2025 (Million USD)
Fig Polymer-Dox Conjugates Market Forecast and CAGR 2019-2025 (Volume)
Fig Polymer-Paclitaxel Conjugates Market Size and CAGR 2013-2018 (Million USD)
Fig Polymer-Paclitaxel Conjugates Market Size and CAGR 2013-2018 (Volume)
Fig Polymer-Paclitaxel Conjugates Market Forecast and CAGR 2019-2025 (Million USD)
Fig Polymer-Paclitaxel Conjugates Market Forecast and CAGR 2019-2025 (Volume)
Fig Polymer-Camptothecin Conjugates Market Size and CAGR 2013-2018 (Million USD)
Fig Polymer-Camptothecin Conjugates Market Size and CAGR 2013-2018 (Volume)
Fig Polymer-Camptothecin Conjugates Market Forecast and CAGR 2019-2025 (Million USD)
Fig Polymer-Camptothecin Conjugates Market Forecast and CAGR 2019-2025 (Volume)
Fig Polymer-Platinate Conjugates Market Size and CAGR 2013-2018 (Million USD)
Fig Polymer-Platinate Conjugates Market Size and CAGR 2013-2018 (Volume)
Fig Polymer-Platinate Conjugates Market Forecast and CAGR 2019-2025 (Million USD)
Fig Polymer-Platinate Conjugates Market Forecast and CAGR 2019-2025 (Volume)
  • Global and China Amifostine Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2019        Price: US 2000 Onwards        Pages: 72
    Summary Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol. Market Segment as follows: By Type - 400mg/Dose - 500mg/Dose By Application - Ovarian Cancer Adjuvant Therapy - Head and Neck Cancer Adjuvant Therapy - Others By Company - Clini......
  • Global (United States, European Union and China) Hepatocellular Carcinoma Drugs Market Research Report 2019-2025
    Published: 16-Aug-2019        Price: US 3280 Onwards        Pages: 118
    HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The disease originates in the liver unlike the secondary liver cancers which reaches to the liver from other organs of the body. Currently only two drugs NEXAVAR and STIVARGA are approved for the treatment of the disease. The incidence rate of hepatic cancer such as intrahepatic bile duct cancer in U.S. was approximately 39,230 during 2017. The risk ......
  • Global and China Cytotoxic Drug Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2019        Price: US 2000 Onwards        Pages: 73
    Summary Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably.......
  • Global and China Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2019        Price: US 2000 Onwards        Pages: 91
    Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Segment as follows: By Type - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer ......
  • Global and China Capecitabine Market Research by Company, Type & Application 2013-2025
    Published: 16-Aug-2019        Price: US 2000 Onwards        Pages: 76
    Summary Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer......
  • Global and China Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2019        Price: US 2000 Onwards        Pages: 89
    Summary Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cance......
  • Global (United States, European Union and China) Ovarian Cancer Drugs Market Research Report 2019-2025
    Published: 14-Aug-2019        Price: US 3280 Onwards        Pages: 117
    Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment at an advanced stage difficult. In 2019, the market size of Ovarian Cancer Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China,......
  • Global Renal Cell Carcinoma Drug Industry Market Research Report
    Published: 13-Aug-2019        Price: US 2960 Onwards        Pages: 139
    The Renal Cell Carcinoma Drug market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Renal Cell Carcinoma Drug industrial chain, this report mainly elaborates the definition, types, applications and major players of Renal Cell Carcinoma Drug market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterpris......
  • Global Gemcitabine Hydrochloride Industry Market Research Report
    Published: 13-Aug-2019        Price: US 2960 Onwards        Pages: 116
    The Gemcitabine Hydrochloride market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Gemcitabine Hydrochloride industrial chain, this report mainly elaborates the definition, types, applications and major players of Gemcitabine Hydrochloride market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterpris......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs